A Two-Stage, Open-Label, Randomized, Crossover Study Evaluating the Pharmacokinetics of Single Doses of Two Investigational Rifaximin Soluble Solid Dispersion Formulations (Immediate Release and Sustained Extended Release) in Healthy Volunteers
Latest Information Update: 16 May 2018